AcquisitionOther
Trillium Therapeutics Inc. acquired Trillium Therapeutics,
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Trillium Therapeutics Inc. -> Trillium Therapeutics, · $18.50
As Trillium becomes part of Pfizer, it brings an impressive portfolio that includes biologics that are designed to enhance the ability of patients' innate immune system to detect and destroy cancer cells.
Open source record (SEC) ↗